Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer's Disease.

Yi-Wen LinChih-Hsiang FangYa-Jyun LiangChing-Yun YangWei-Ting KuoFeng-Huei Lin

Published in: Biomaterials research (2023)

Our findings suggest that treatment with clenbuterol loaded in this SHAP delivery system could be a promising strategy for treating Alzheimer's disease.

Keyphrases

cognitive decline
cancer therapy